Emerging biomarkers of acute kidney injury

Contributions to Nephrology

Volumn 156, Issue , 2007, Pages 203-212

  Devarajan, Prasad ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CYSTATIN; CYSTATIN C; HAVCR1 PROTEIN, HUMAN; INTERLEUKIN 18; LCN2 PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD; HOSPITALIZATION; HUMAN; PROGNOSIS; SENSITIVITY AND SPECIFICITY; URINE;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CYSTATINS; HUMANS; INTERLEUKIN-18; KIDNEY FAILURE, ACUTE; MEMBRANE GLYCOPROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 34247638679     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102085     Document Type: Article

References (44)

1. Lameire N, Van Biesen W, Vanholder R: Acute renal failure. Lancet 2005;365:417-430.
2. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004;114:5-14.
3. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-818.
4. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006;17: 1503-1520.
5. Schrier RW: Need to intervene in established acute renal failure. J Am Soc Nephrol 2004;15: 2756-2758.
6. Hewitt SM, Dear J, Star RA: Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004;15:1677-1689.
7. Herget-Rosenthal S, Marggraf G, Hüsing J, Goring F, Pietruck F, Janssen O, Phillip T, Kribben A: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115-1122.
8. Bellomo R, Kellum JA, Ronco C: Defining acute renal failure: physiological principles. Intensive Care Med 2004;30:33-37.
9. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH: Anaritide in acute tubule necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997;336:828-834.
10. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, Pike M, Guler H-P: Multicenter clinical trial of recombinant human insulin-like growth factor 1 in patients with acute renal failure. Kidney Int 1999;55:2423-2432.
11. American Society of Nephrology: American Society of Nephrology Renal Research Report. J Am Soc Nephrol 2005;16:1886-1893.
12. Zerhouni E: The NIH roadmap. Science 2003;302:63-65.
13. Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS: Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 2003;80:365-376.
14. Han WK, Bonventre JV: Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 2004;10:476-482.
15. Zhou H, Hewitt SM, Yuen PST, Star RA: Acute kidney injury biomarkers - needs, present status, and future promise. Nephrology Self Assessment Program, American Society of Nephrology. NephSAP 2006;5:63-71.
16. Nguyen M, Ross G, Dent C, Devarajan P: Early prediction of acute renal injury using urinary proteomics. Am J Nephrol 2005;25:318-326.
17. Xu S, Venge P: Lipocalins as biochemical markers of disease. Biochim Biophys Acta 2000;1482:298-307.
18. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P: Differential gene expression following early renal ischemia-reperfusion. Kidney Int 2003;63:1714-1724.
19. Mishra J, Ma Q, Prada A, Zahedi K, Yang Y, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 2003;4:2534-2543.
20. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P: Neutrophil Gelatinase-Associated Lipocalin (NGAL): a novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24:307-315.
21. Mori K, Lee HT, Rapoport D, Drexler I, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005;115:610-621.
22. Schmitt-Ott KM, Mori K, Kalandadze A, Li J-Y, Paragas N, Nicholas T, Devarajan P, Barasch J: Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2005;15:442-449.
23. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 2005;365:1231-1238.
24. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006;105:485-491.
25. Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori K, Barasch J, Devarajan P: Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006;21:856-863.
26. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelstein CL, Devarajan P: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006;6:1639-1645.
27. Trachtman H, Christen E, Cnaan A, Patrick J, Mai V, Mishra J, Jain A, Bullington N, Devarajan P: Urinary neutrophil gelatinase-associated lipocalin in D+HUS: A novel marker of renal injury. Pediatr Nephrol 2006;21:989-994.
28. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S: Neutrophil gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006;26:287-292.
29. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S: Could NGAL predict renal function after percutaneous coronary interventions? J Am Soc Nephrol 2006;17:406A.
30. Devarajan P, Hirsch R, Dent C, Pfriem H, Allen J, Beekman R, Mishra J, Ma Q, Kelly C, Mitsnefes M: NGAL is an early predictive biomarker of acute kidney injury following contrast administration. J Am Soc Nephrol 2006;17:48A.
31. Zappitelli M, Washburn K, Arikan AA, Mishra J, Loftis L, Devarajan P, Goldstein SL: Urine NGAL is an early predictive biomarker of acute kidney injury in critically ill children. J Am Soc Nephrol 2006;17:404A.
32. Mitsnefes M, Kathman T, Mishra J, Kartal J, Khoury P, Nickolas T, Barasch J, Devarajan P: Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007;22:101-108.
33. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40:221-226.
34. Herget-Rosenthal S, Poppen D, Husing J, Marggraf G, Pietruck F, Jakob HG, Phillip T, Kribben A: Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004;50:552-558.
35. VandeVoorde RG, Katlman TI, Ma Q, Kelly C, Mishra J, Dent CA, Mitsnefes MM, Devarajan P: Serum NGAL and cystatin C as predictive biomarkers for acute kidney injury. J Am Soc Nephrol 2006;17:404A.
36. Han WK, Bailly V, Abichandani R, Thadani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62:237-244.
37. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV: Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004;286: F552-F563.
38. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV: Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006;290:F517-F529.
39. Liangos O, Han WK, Wald R, Perianayagam MC, Mackinnon RW, Dolan N, Warner KG, Symes JF, Bonventre JV, Jaber BL: Urinary kidney injury molecule-1 level is an early and sensitive marker of acute kidney injury following cardiopulmonary bypass. J Am Soc Nephrol 2006;17:403A.
40. Han WK, Waikar SS, Johnson A, Curhan GC, Devarajan P, Bonventre JV: Urinary biomarkers for early detection of acute kidney injury. J Am Soc Nephrol 2006;17:403A.
41. Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, Schrier RW, Edelstein CL: Impaired IL-18 processing protects caspase-1 deficient mice from ischemic acute renal failure. J Clin Invest 2001;107:1145-1152.
42. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004;43:405-414.
43. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005;16:3046-3052.
44. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006;70:199-203.